| Open | 1220 |
| LTP | 1230 |
| Previous Close | 1228.1 |
| Day High | 1235.5 |
| Day Low | 1219.6 |
| Volume | 9921 |
| Code : | TATVA |
| Name : | Tatva Chintan Pharma Chem Limited |
| Country : | India |
| Sector : | Speciality Chemicals |
| Industry: | Specialty Chemicals |
| Market CAP : | 2,860 Cr |
| Stock P/E: | 72.65 |
| ROCE: | 7.56% |
| Book Value: | 320.63 |
| Dividend Yield : | 0.16% |
| Most Recent Quarter : | 2023-12-31 |
| Revenue/Sales TTM : | 420 Cr |
| Operating Margin TTM : | 0.0524% |
| Return On Equity TTM : | 0.08% |
| Profit Margin : | 0.09% |
| Market Capitalization : | 2,860 Cr |
| EBITDA : | 65 Cr |
| Book Value : | 320.63 |
| PERatio : | 72.65 |
| Dividend Share : | 0 |
| Earnings Share : | 16.82 |
| Gross Profit TTM : | 191 Cr |
| Quarterly Earnings Growth YOY : | -0.72% |
| Dividend Yield : | 0.0016% |
| Quarterly Revenue GrowthYOY : | -0.3 |
| Diluted Eps TTM : | 16.82 |
| Trailing PE : | 72.65 |
| Price Sales TTM : | 7.06 |
| Enter Prise Value : | 2,784 Cr |
| Enter Prise Value Ebidta : | 41.8809 |
| Forward PE : | 0 |
| Price Book MRQ : | 4.07 |
| Enter Prise Value Revenue : | 6.9 |
| Forward Annual Dividend Rate : | 2 |
| Payout Ratio : | 0.22 |
| Ex Dividend Date : | 2023-09-08 |
| Last Split Date : | 0000-00-00 |
| Forward Annual Dividend Yield : | 0.0016 |
| Dividend Date : | 0000-00-00 |
| Last Split Factor : |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 1237.13 | 1244.27 | 1253.03 | 1228.37 | 1221.23 | 1212.47 | 1205.33 |
| Fibonacci | 1232.95 | 1242.18 | 1248.85 | 1226.28 | 1217.05 | 1210.38 | 1201.15 |
| Camarilla | 1237.95 | 1244.68 | 1253.85 | 1228.78 | 1222.05 | 1212.88 | 1206.15 |
| Classic | 1227.95 | 1239.68 | 1243.85 | 1223.78 | 1212.05 | 1207.88 | 1196.15 |
| Days 50 Day MA |
1211.56 |
| Days 200 Day MA |
1465.21 |
| Days 52 Week High |
1885.64 |
| Days 52 Week Low |
1061.35 |
| Quarterly | Sale | Expense | Net Income | Other Operating Expenses | Interest Expense | Tax Provision | EBIT | NetInterest Income | Income Tax Expense |
| Dec 2023 | 84 Cr | 42 Cr | 3 Cr | 80 Cr | 38 Lac | 2 Cr | 6 Cr | 0 Cr | 2 Cr |
| Sep 2023 | 97 Cr | 46 Cr | 8 Cr | 83 Cr | 3 Cr | 3 Cr | 14 Cr | -3 Cr | 3 Cr |
| Jun 2023 | 114 Cr | 41 Cr | 10 Cr | 99 Cr | 3 Cr | 4 Cr | 16 Cr | -3 Cr | 4 Cr |
| Mar 2023 | 125 Cr | 36 Cr | 17 Cr | 111 Cr | 3 Cr | -9 Cr | 15 Cr | -3 Cr | -9 Cr |
| Yearly | Sale | Expense | Net Income | Other Operating Expenses | Interest Expense | Tax Provision | Interest Income | Net Interest Income | Income Tax Expense |
| Mar 2023 | 424 Cr | 146 Cr | 45 Cr | 373 Cr | 8 Cr | -1 Cr | 5 Cr | -8 Cr | -1 Cr |
| Mar 2022 | 431 Cr | 123 Cr | 96 Cr | 331 Cr | 4 Cr | 8 Cr | 5 Cr | -5 Cr | 8 Cr |
| Mar 2021 | 297 Cr | 81 Cr | 52 Cr | 236 Cr | 4 Cr | 8 Cr | 36 Lac | -4 Cr | 8 Cr |
| Mar 2020 | 258 Cr | 66 Cr | 38 Cr | 204 Cr | 4 Cr | 10 Cr | 52 Lac | -4 Cr | 10 Cr |
| Quarterly | Total Assets | Total Current Assets | Inventory | Total Liab | Other Liab | Total Current Liabilities | Total Stock holder Equity |
| Dec 2023 | 0 | 144 Cr | 0 | 0 | 0 | 0 | 727 Cr |
| Sep 2023 | 840 Cr | 371 Cr | 143 Cr | 113 Cr | 0 | 110 Cr | 727 Cr |
| Jun 2023 | 0 | 45 Cr | 0 | 0 | 0 | 0 | 515 Cr |
| Mar 2023 | 756 Cr | 314 Cr | 162 Cr | 242 Cr | 0 | 236 Cr | 515 Cr |
| Yearly | Total Assets | Total Current Assets | Inventory | Total Liab | Other Liab | Total Current Liabilities | Total Stock holder Equity |
| Mar 2023 | 756 Cr | 314 Cr | 162 Cr | 242 Cr | 0 | 236 Cr | 515 Cr |
| Mar 2022 | 658 Cr | 436 Cr | 170 Cr | 185 Cr | 67 Lac | 171 Cr | 473 Cr |
| Mar 2021 | 315 Cr | 184 Cr | 72 Cr | 149 Cr | 4 Cr | 118 Cr | 166 Cr |
| Mar 2020 | 249 Cr | 133 Cr | 64 Cr | 131 Cr | 5 Cr | 88 Cr | 118 Cr |
| Quarterly | Change To Net income | Dividends Paid | Change To Inventory | Investments | Net Income | Depreciation | Capital Expenditures |
| Dec 2023 | 0 | 0 | 0 | 0 | 3 Cr | 7 Cr | 0 |
| Sep 2023 | 0 | 0 | 0 | 0 | 8 Cr | 7 Cr | 0 |
| Jun 2023 | 0 | 0 | 0 | 0 | 10 Cr | 6 Cr | 0 |
| Mar 2023 | 0 | 0 | 0 | 0 | 17 Cr | 3 Cr | 0 |
| Yearly | Change To Net income | Dividends Paid | Change To Inventory | Investments | Net Income | Depreciation | Capital Expenditures |
| Mar 2023 | 0 | 4 Cr | 7 Cr | -101 Cr | 45 Cr | 10 Cr | 203 Cr |
| Mar 2022 | -8 Cr | 4 Cr | -98 Cr | -112 Cr | 104 Cr | 8 Cr | 89 Cr |
| Mar 2021 | 3 Cr | 4 Cr | -8 Cr | 25 Lac | 61 Cr | 7 Cr | 21 Cr |
| Mar 2020 | 5 Cr | 4 Cr | -28 Cr | 7 Cr | 48 Cr | 5 Cr | 48 Cr |
| Date | Target 3 | Target 2 | Target 1 | Trading Levels | Target 1 | Target 2 | Target 3 | |
|---|---|---|---|---|---|---|---|---|
| 2024-05-02 | 1,644.05 | 1,648.20 | 1,654.00 | 1,660.65 |
1,667.30 |
1,673.95 | 1,679.80 | 1,683.95 |
| Date | Opening price | Closing price | Minimum price | Maximum price |
|---|---|---|---|---|
| 2024-04-25 | 1250 | 1244.7 | 1235 | 1266.6 |
| 2024-04-26 | 1250 | 1239.9 | 1230.05 | 1259 |
| 2024-04-29 | 1239.9 | 1229.3 | 1221.05 | 1253.95 |
| 2024-04-30 | 1237.8 | 1228.1 | 1220 | 1240 |
| 2024-05-02 | 1220 | 1228.15 | 1219.6 | 1235.5 |
Tatva Chintan Pharma Chem Limited engages in manufacture and sale of specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor and zinc ion batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also engages in trading of specialty chemicals. The company serves various industries, including the automotive, petroleum, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. It also exports its products to various countries, including the United States, Singapore, the United Kingdom, China, Germany, Japan, and South Africa. The company was incorporated in 1996 and is headquartered in Vadodara, India.
| Open | 1220 |
| LTP | 1230 |
| Previous Close | 1228.1 |
| Day High | 1235.5 |
| Day Low | 1219.6 |
| Volume | 9921 |
| Company Name | Price | Change | % Chg | Day High | Day Low | Previous Close | Volume |
|---|---|---|---|---|---|---|---|
| Vikas Ecotech | 3.95 | 0.05 | 1.28 | 3.95 | 3.85 | 3.9 | 4099552 |
| Clean Science | 1313 | -7.7 | -0.58 | 1328.85 | 1306.15 | 1320.7 | 68436 |
| Vikas WSP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Company HEROMOTOCO |
LTP 4551 |
Change 99.9 |
Gain 2.24 % |
|
Company INDUSINDBK |
LTP 1509 |
Change 19.75 |
Gain 1.33 % |
|
Company BAJFINANCE |
LTP 6903.05 |
Change 79.1 |
Gain 1.16 % |
|
Company BAJAJFINSV |
LTP 1614 |
Change 18.35 |
Gain 1.15 % |
|
Company MARUTI |
LTP 12800 |
Change 100 |
Gain 0.79 % |
New Delhi: Shares of Tatva Chintan Pharma Chem dropped 9 per cent in Tuesday's trade following a weak operating performance in the quarter ended December 31, 2021.The company reported a 9 per cent year-on-year (YOY) rise in consolidated net profit at Rs 22.8 crore in the December 2021 quarter, with a 31 per cent YoY jump in total revenue to Rs 104.67 crore.The Ebitda declined 6 per cent to Rs 23 c...
Nifty futures on the Singapore Exchange traded 22 points, or 0.13 per cent higher at 17,112, signaling that Dalal Street was headed for a positive start on Tuesday. Here are a dozen stocks which may buzz the most in today's trade:Go Fashion: The leading player of women's bottom wear will make its Dalal Street Debut on Monday. The company sold its shares in the range of Rs 655-690 between November...
Specialty chemical manufacturing company Tatva Chintan Pharma Chem said that Mahesh Tanna, Chief Financial Officer (CFO) of the company has tendered his resignation from the post of Chief Financial Officer and Key Managerial Personnel on 24" August, 2021. "The company has accepted his resignation and he will be relieved from the Company with effect from 31 August, 2021 after closure of working ...
Specialty Chemical manufacturer Tatva Chintan Pharma Chem is expected to make its stock market debut on Thursday i.e., July 29. Its issue price was fixed at Rs1,073-1,083 apiece. The share allotment of the initial public offering (IPO), that had opened for subscription on July 16 and closed on July 20, was finalized on Wednesday.The Rs500 crore IPO was subscribed nearly 180 times on the final day ...
Tatva Chintan IPO: After t finalisation of share allotment, all eyes are now set on Tatva Chintan IPO listing date i.e. 29th July 2021. However, before listing of Tatava Chintan shares at NSE and BSE, grey market has already started signaling the bullish expectations of the markets. According to the stock market observers, Tatva Chintan IPO GMP (grey market premium) today is Rs1150, which is Rs90 ...
anibillon02 2022-07-26 15:06:16
so keep buying its going to grow superb 10 times investment tgt even also keep buying aether ind its also 10 times tgt and clean science 4-5 times tgt
Login & Reply Like(0) Dislike(0) Repost Spam